U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 1741 - 1750 of 1957 results

Status:
US Approved OTC
Source:
21 CFR 349.12(a)(4) ophthalmic:demulcents methylcellulose
Source URL:

Class:
POLYMER

Status:
US Approved OTC
Source:
21 CFR 349.12(a)(4) ophthalmic:demulcents methylcellulose
Source URL:

Class:
POLYMER

Status:
US Approved OTC
Source:
21 CFR 349.12(a)(3) ophthalmic:demulcents hypromellose
Source URL:

Class:
POLYMER

structurally diverse
Status:
US Approved Rx (2021)
Source:
BLA125714
(2021)
Source URL:
First approved in 2021
Source:
BLA125714
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (2021)
Source:
BLA125736
(2021)
Source URL:
First approved in 2021
Source:
BLA125736
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Rx (2020)
Source:
BLA125696
(2020)
Source URL:
First approved in 2020
Source:
BLA125696
Source URL:

Class:
STRUCTURALLY DIVERSE

Showing 1741 - 1750 of 1957 results